virtus respiratory research limited Company Information
Company Number
11572125
Website
virtus-rr.comRegistered Address
gowran house 56 broad street, chipping sodbury, bristol, BS37 6AG
Industry
Research and experimental development on biotechnology
Telephone
02075545855
Next Accounts Due
December 2024
Group Structure
View All
Shareholders
sebastian lennox johnston 75%
michael robert edwards 25%
virtus respiratory research limited Estimated Valuation
Pomanda estimates the enterprise value of VIRTUS RESPIRATORY RESEARCH LIMITED at £405.3k based on a Turnover of £308.8k and 1.31x industry multiple (adjusted for size and gross margin).
virtus respiratory research limited Estimated Valuation
Pomanda estimates the enterprise value of VIRTUS RESPIRATORY RESEARCH LIMITED at £0 based on an EBITDA of £-457.8k and a 5.27x industry multiple (adjusted for size and gross margin).
virtus respiratory research limited Estimated Valuation
Pomanda estimates the enterprise value of VIRTUS RESPIRATORY RESEARCH LIMITED at £1.4m based on Net Assets of £599.8k and 2.29x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Virtus Respiratory Research Limited Overview
Virtus Respiratory Research Limited is a live company located in bristol, BS37 6AG with a Companies House number of 11572125. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in September 2018, it's largest shareholder is sebastian lennox johnston with a 75% stake. Virtus Respiratory Research Limited is a young, micro sized company, Pomanda has estimated its turnover at £308.8k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Virtus Respiratory Research Limited Health Check
Pomanda's financial health check has awarded Virtus Respiratory Research Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
2 Regular
5 Weak
Size
annual sales of £308.8k, make it smaller than the average company (£2.9m)
- Virtus Respiratory Research Limited
£2.9m - Industry AVG
Growth
3 year (CAGR) sales growth of -12%, show it is growing at a slower rate (13.1%)
- Virtus Respiratory Research Limited
13.1% - Industry AVG
Production
with a gross margin of 54.3%, this company has a comparable cost of product (54.3%)
- Virtus Respiratory Research Limited
54.3% - Industry AVG
Profitability
an operating margin of -152.6% make it less profitable than the average company (-0.1%)
- Virtus Respiratory Research Limited
-0.1% - Industry AVG
Employees
with 4 employees, this is below the industry average (40)
4 - Virtus Respiratory Research Limited
40 - Industry AVG
Pay Structure
on an average salary of £71.1k, the company has an equivalent pay structure (£71.1k)
- Virtus Respiratory Research Limited
£71.1k - Industry AVG
Efficiency
resulting in sales per employee of £77.2k, this is less efficient (£127.1k)
- Virtus Respiratory Research Limited
£127.1k - Industry AVG
Debtor Days
it gets paid by customers after 12 days, this is earlier than average (51 days)
- Virtus Respiratory Research Limited
51 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Virtus Respiratory Research Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Virtus Respiratory Research Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 1843 weeks, this is more cash available to meet short term requirements (33 weeks)
1843 weeks - Virtus Respiratory Research Limited
33 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 3.7%, this is a lower level of debt than the average (50%)
3.7% - Virtus Respiratory Research Limited
50% - Industry AVG
VIRTUS RESPIRATORY RESEARCH LIMITED financials
Virtus Respiratory Research Limited's latest turnover from March 2023 is estimated at £308.8 thousand and the company has net assets of £599.8 thousand. According to their latest financial statements, Virtus Respiratory Research Limited has 4 employees and maintains cash reserves of £516.7 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
---|---|---|---|---|---|
Turnover | |||||
Other Income Or Grants | |||||
Cost Of Sales | |||||
Gross Profit | |||||
Admin Expenses | |||||
Operating Profit | |||||
Interest Payable | |||||
Interest Receivable | |||||
Pre-Tax Profit | |||||
Tax | |||||
Profit After Tax | |||||
Dividends Paid | |||||
Retained Profit | |||||
Employee Costs | |||||
Number Of Employees | 4 | 3 | 3 | 4 | 4 |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
---|---|---|---|---|---|
Tangible Assets | 53,785 | 54,573 | 49,932 | 21,603 | 9,269 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 53,785 | 54,573 | 49,932 | 21,603 | 9,269 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 10,617 | 124,584 | 216,644 | 0 | 0 |
Group Debtors | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 41,776 | 479,719 | 308,565 | 112,773 | 33,927 |
Cash | 516,671 | 402,958 | 223,768 | 398,623 | 656,934 |
misc current assets | 0 | 0 | 0 | 0 | 0 |
total current assets | 569,064 | 1,007,261 | 748,977 | 511,396 | 690,861 |
total assets | 622,849 | 1,061,834 | 798,909 | 532,999 | 700,130 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 14,574 | 0 | 2,324 | 244,830 | 571,973 |
total current liabilities | 14,574 | 0 | 2,324 | 244,830 | 571,973 |
loans | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 |
provisions | 8,488 | 10,369 | 9,487 | 4,105 | 1,761 |
total long term liabilities | 8,488 | 10,369 | 9,487 | 4,105 | 1,761 |
total liabilities | 23,062 | 10,369 | 11,811 | 248,935 | 573,734 |
net assets | 599,787 | 1,051,465 | 787,098 | 284,064 | 126,396 |
total shareholders funds | 599,787 | 1,051,465 | 787,098 | 284,064 | 126,396 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
---|---|---|---|---|---|
Operating Activities | |||||
Operating Profit | |||||
Depreciation | 13,446 | 13,644 | 12,483 | 5,400 | 2,317 |
Amortisation | 0 | 0 | 0 | 0 | 0 |
Tax | |||||
Stock | 0 | 0 | 0 | 0 | 0 |
Debtors | -551,910 | 79,094 | 412,436 | 78,846 | 33,927 |
Creditors | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 14,574 | -2,324 | -242,506 | -327,143 | 571,973 |
Deferred Taxes & Provisions | -1,881 | 882 | 5,382 | 2,344 | 1,761 |
Cash flow from operations | |||||
Investing Activities | |||||
capital expenditure | |||||
Change in Investments | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||
Financing Activities | |||||
Bank loans | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 |
share issue | |||||
interest | |||||
cash flow from financing | |||||
cash and cash equivalents | |||||
cash | 113,713 | 179,190 | -174,855 | -258,311 | 656,934 |
overdraft | 0 | 0 | 0 | 0 | 0 |
change in cash | 113,713 | 179,190 | -174,855 | -258,311 | 656,934 |
virtus respiratory research limited Credit Report and Business Information
Virtus Respiratory Research Limited Competitor Analysis
Perform a competitor analysis for virtus respiratory research limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in BS37 area or any other competitors across 12 key performance metrics.
virtus respiratory research limited Ownership
VIRTUS RESPIRATORY RESEARCH LIMITED group structure
Virtus Respiratory Research Limited has no subsidiary companies.
Ultimate parent company
VIRTUS RESPIRATORY RESEARCH LIMITED
11572125
virtus respiratory research limited directors
Virtus Respiratory Research Limited currently has 3 directors. The longest serving directors include Mr Michael Edwards (Sep 2018) and Mr Michael Edwards (Sep 2018).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Michael Edwards | United Kingdom | 52 years | Sep 2018 | - | Director |
Mr Michael Edwards | United Kingdom | 51 years | Sep 2018 | - | Director |
Prof Sebastian Johnston | United Kingdom | 65 years | Sep 2018 | - | Director |
P&L
March 2023turnover
308.8k
-51%
operating profit
-471.2k
0%
gross margin
54.4%
+10.43%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
599.8k
-0.43%
total assets
622.8k
-0.41%
cash
516.7k
+0.28%
net assets
Total assets minus all liabilities
virtus respiratory research limited company details
company number
11572125
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
September 2018
age
6
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2023
previous names
N/A
accountant
-
auditor
-
address
gowran house 56 broad street, chipping sodbury, bristol, BS37 6AG
Bank
-
Legal Advisor
-
virtus respiratory research limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to virtus respiratory research limited.
virtus respiratory research limited Companies House Filings - See Documents
date | description | view/download |
---|